Carcinogens induce intrachromosomal recombination in yeast

Carcinogenesis

Volumn 10, Issue 8, 1989, Pages 1445-1455

  Schiestl, Robert H ^a,b   Gietz, R Daniel ^a,b   Mehta, R D ^c   Hastings, P J ^d  

^a UNIVERSITY OF ROCHESTER   (United States)

^b GeneBioMed Inc ^*  (United States)

^c Prairie Biological Research ^*  (Canada)

^d UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOGEN;

CHROMOSOME ABERRATION; FUNGUS; NONHUMAN; SACCHAROMYCES CEREVISIAE; YEAST;

CARCINOGENICITY TESTS; CARCINOGENS; CHROMOSOMES; GENES, FUNGAL; MUTAGENS; PLASMIDS; RECOMBINATION, GENETIC; SACCHAROMYCES CEREVISIAE; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0024336056     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/10.8.1445     Document Type: Article

References (56)

1. Lave L B. and Omenn G.S. (1986) Cost-effectiveness of short-term tests for carcinogenicity. Nature, 324, 29-34.
2. Sivak A., Goyer M.M. and Ricci P.F. (1987) Nongenotoxic carcinogens: prologue. In Butterwoith.B.E. and Slaga, T.J. (eds), Nongenotoxic Mechanisms in Carcinogenesis, 25 Banbury Report. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY, pp. 1-8.
3. Zeiger E. (1987) Carcinogenicity of mutagens: predictive capability of the Salmonella mutagenesis assay for rodent carcinogenicity. Cancer Res., 47, 1287-1296.
4. Tennant R.W., Margolin B.H., Shelby M.D., Zeiger E., Haseman J.K., Spalding J., Caspsry W., Resnick M., Stasiewicz S., Anderson B. and Minor R. (1987) Prediction of chemical carcinogenicity in rodents from in vitro genetic toxicity assays. Science, 236, 933-941.
5. Ricci P.F. and Melton L.S. (1985) Regulating cancer risks. Environ. Sci. Technol., 19, 437.
6. Marx J.L. (1982) The case of the misplaced gene. Science, 218, 983-985.
7. Klein G. (1981) The role of gene dosage and genetic transposition in carcinogenesis. Nature, 294, 313-318.
8. Pall M.L. (1981) Gene-amplification model of carcinogenesis. Proc. Natl. Acad. Sci. USA, 78, 2465-2468.
9. Cairns C(1981) The origin of human cancers. Nature, 289, 353-357.
10. Wintersberger U. (1982) Chemical carcinogenesis—the price for DNA repair? Natunvissenschaften, 69, 107-113.
11. Hansen M.F. and Cavanee W.K. (1988) Tumor suppressors: recessive mutations that lead to cancer. Cell, 53, 172-173.
12. Ponder B. (1988) Gene losses in human tumors. Nature, 335, 400-402.
13. Schiesd R.H. and Hastings P.J. (1986) Screening of recombination defective mutants with a positive selection system for plasmid excision. In Klar, A.J.S. and Strathem, J.N. (eds), Current Communication in Molecular Biology: Mechanisms of Yeast Recombination. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY, pp. 85-88.
14. Schiestl R.H., Igarashi S. and Hastings PJ. (1988) Analysis of the mechanism for reversion of a disrupted gene. Genetics, 119, 237-247.
15. Schiestl R.H. and Prakash S. (1988) RADI, an excision repair gene of Saccharomyces cerevisiae, is also involved in recombination. Mol. CelL Biol., 8, 3619-3626.
16. Kunz B. and Haynes R. (1981) Phenomenology of genetic recombination in yeast. Annu. Rev. Genet., 15, 57-89.
17. Schiestl R.H. (1989) Nonmutagenic carcinogens induce intrachromosomal recombination in yeast. Nature, 337, 285-288.
18. Fasullo M.T. and Davis R.W. (1987) Recombinational substrates designed to study recombination between unique and repetitive sequences in vivo. Proc. Natl. Acad. Sci. USA, 84, 6215-6219.
19. Schiestl R.H. and Wintersberger U. (1982) X-ray enhances mating type switching in heterothallic strains of Saccharomyces cerevisiae. Mol. Gen. Genet., 186, 512-517.
20. Prakash L. and Prakash S. (1977) Isolation and characterization of MMS- sensitive mutants of Saccharomyces cerevisiae. Genetics, 86, 33-55.
21. Levin D.E., Hollstein M., Christman M.I.F., Schwiers E.A. and Ames B.N.A new Salmonella tester strain (TA 102) with A-T base pairs at the site of mutation detects oxidative mutagens. Proc. Natl. Acad. Sci. USA, 79, 7445-7449.
22. Hesse O. (1911) Symptomatologie, Pathogenese und Therapie des Roentgenkamnomas. Bort, Leipzig.
23. Mc Cann J., Choi E., Yamasaki E. and Ames B.N. (1975) Detection of carcinogens as mutagens in the Saimonellaimicmsome test: assay of 300 chemicals. Proc. Natl. Acad. Sci. USA, 72, 5135-5139.
24. IARC Internationa] Agency for Research on Cancer (1973-1987) ¡ARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Man. IARC, Lyon, Vols 1-41.
25. Flora S.D., Zanacchi P., Camoirano A., Bemecelli C. and Badolali G.S. (1984) Genotoxic activity of 135 compounds in the Ames reversion test and in a bacteria] DNA repair test. Mutat. Res., 133, 161-198.
26. DeSerrcs FJ. and Ashby J. (eds) (1981) Evaluation of short term tests for carcinogens, Progress in Mutation Research, Vol. 1
27. Zimmermann F.K., von Borstel R.C., Halle E.S., Parry J.M., Siebert D., Barale R. and Loprieno N. (1984) Testing of chemicals for genetic activity with Saccharomyces cerevisiae: a report of the US Environmental Protection Agency Gene-Tox Program. Mutat. Res., 133, 199-244.
28. Ashby J. and Tennant R.W. (1988) Chemical structure, Salmonella mutagenicity and extent of carcinogenicity as indicators of genotoxic carcinogenesis among 222 chemicals tested in rodents by the U.S. NCI/NTP. Mutat. Res., 204, 17-115.
29. Milman H.A. and Wetsburger E.K. (eds) (1985) Handbook of Carcinogen Testing. Noyes, Park Ridge, NJ.
30. Butterworth E.B. and Slaga T.J. (1987) Nongenotoxic Mechanisms in Carcinogenesis, 25 Banbury Report. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY.
31. von Borstel R.C. and Mehta R.D. (1982) Nonmutagenic carcinogens. In Mutagens in our Environment. Alan R.Liss, New York, pp. 47-57.
32. Sittig M. (1985) Handbook of Toxic and Hazardous Chemicals and Carcinogens. Noyes, Park Ridge, NJ.
33. Zimmermann F.K. (1983) Cellular systems for toxicity testing. Ann. N.Y. Acad. Sci., 407, 186-196.
34. Boyland E., Busby E.R., Dukes C.E., Grover P.L. and Manson D. (1964) Further experiments on implantation of materials into the urinary bladder of mice. Br. J. Cancer, 18, 575-581.
35. Yamamoto R.S., Weisburger E.K. and Korzis J. (1967) Chronic administration of hydroxylamine and derivatives in mice. Proc. Soc. Exp. Biol. Med., 124, 1217-1220.
36. Busby S., Irani M. and Crombrugghe B. (1982) Isolation of mutant promoters in the Escherichia coli galactose operon using local mutagenesis on cloned DNA fragments. J. Mol. BioL, 154, 197-209.
37. Drake J.W. (1970) The Molecular Basis of Mutation. Holden-Day, San Francisco.
38. Skavronskaya A.G. and Pokrovskii V.N. (1966) Induction of auxotrophy under the influence of 5-bromouracil in Salmonella typhimurium LT 2. Soviet Genet., 2, 77-81.
39. Ryderberg B. (1977) Bromouracil mutagenesis in Escherichia coli evidence for involvement of mismatch repair. Mol. Gen. Genet., 152, 19-28.
40. Hutchinson F. and Steind S (1977) Mutagenesis of lambda phage: 5-bromouracil and hydroxylamine. Mol. Gen. Genet., 152, 29-36.
41. Nagley P. and Wake R.G. (1969) Effect of 5-bromouracil on pattern of deoxyribonucleic acid replication in germinating Bacillus subtilis spores. J. Mol BioL, 43, 619-630.
42. Brown G.B. (1968) Purine N-oxides and cancer. Progr. Nucleic Acid Res. Mol. Biol., 8, 209-255.
43. Podger D.M., Grigg G.W. and MacPhee D.G. (1983) Ethionine abolishes mutagenesis by 9-aminoacridine (but not by 2-aminopurine) in Salmonella plate tests. Mutat. Res., 119, 113-120.
44. Skmmski P.P., Perrodin G. and Croft J.H. (1968) Ethidium bromide-induced mutation of yeast mitochondria: complete transformation of cells into respiratory deficient nonchromosomal ‘petites’. Biochem. Biophys. Res. Commute, 30, 232-239.
45. Shelby M.D. (1988) The genetic toxicity of human carcinogens and its implications. Mutat. Res., 204, 3-15.
46. Parry J.M., Parry E.M. and Barrett J.C. (1981) Tumour promoters induce mitotic aneuploidy in yeast. Nature, 294, 263-265.
47. Datta A.R., Randolph B.W. and Rosner J.L. (1983) Detection of chemicals that stimulate Tn9 transposition in Escherichia coli K12. Mol Gen. Genet., 189, 245-250.
48. Kaneko T, Nomura S. and Oishi M. (1984) Early events leading to erythroid differentiation in mouse friend cells revealed by cell fusion experiments. Cancer Res., 44, 1756-1760.
49. Wieder R., Wogan G.N. and Shimkin M.B. (1968) Pulmonary tumors in strain A mice given injections of aflatoxin B, J. Natl. Cancer Inst., 40, 1195-1197.
50. Shimkin M.B., Weisburger J.H., Weisburger E.K., Gubareff N. and Suntzeff V. (1966) Bioassay of 29 alkylating chemicals by the pulmonary- tumor response in strain A mice. J. Natl. Cancer Inst., 36, 915-935.
51. Clapp N.K., Craig A.W. and Toya R.E., Sr (1968) Oncogenicity by methyl methanesulfonate in male RF mice. Science, 161, 913-914.
52. Stoner G.D. and Shimkin M.B. (1985) Lung tumors in strain A mice as a bioassay for carcinogenicity. In Milman.H.A. and Weisburger.E.K. (eds) Handbook of Carcinogen Testing. Noyes, Park Ridge, NJ, pp. 179-214.
53. Kerns W.D., Pavkov K.L., Donofrio D.J., Gralia E.J. and Swenberg J.A. Carcinogenicity of formaldehyde in rats and mice after long term inhalation exposure. Cancer Res., 43, 4382-4392.
54. Innes J.R.M., Ulland B.M., Valerio M.G., Petrucelli L., Fishbein L., Hart E.R., Pallotta A.J., Bates R.R., Falk H.L., Gart J.J., Klein M., Mitchell I. and Peters J. (1969) Bioassay of pesticides and industrial chemicals for tumorigenicity in mice: a preliminary note. J. Natl. Cancer Inst., 42, 1101-1114.
55. Kroes R. (1983) Short term tests in the framework of carcinogen risk assessment to man. Ann. N.Y. Acad. Sri., 407, 398-408.
56. Willis E.A., Weksberg R., Tomlinson S. and Lindahl T. (1987) Structural alterations of DNA ligase I in Blooms syndrome. Proc. NatL Acad. Sd. USA, 84, 8016-8020.